A first-in-human phase I study to determine the maximum tolerated dose of the oral Src/ABL inhibitor AZD0424

Victoria K Woodcock, Sally Clive, Richard H Wilson, Vicky M Coyle, Michael R L Stratford, Lisa K Folkes, Richard Eastell, Claire Barton, Paul Jones, Shamim Kazmi-Stokes, Helen Turner, Sarah Halford, Adrian L Harris, Mark R Middleton

Research output: Contribution to journalArticlepeer-review

8 Citations (Scopus)
213 Downloads (Pure)

Fingerprint

Dive into the research topics of 'A first-in-human phase I study to determine the maximum tolerated dose of the oral Src/ABL inhibitor AZD0424'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science